Local injection of bevacizumab (Avastin) and angiolytic KTP laser treatment of recurrent respiratory papillomatosis of the vocal folds: A prospective study

Annals of Otology, Rhinology and Laryngology

Volumn 120, Issue 10, 2011, Pages 627-634

  Zeitels, Steven M ^a   Barbu, Anca M ^a   Landau Zemer, Tali ^a   Lopez Guerra, Gerardo ^a   Burns, James A ^a   Friedman, Aaron D ^a   Freeman, Mason W ^a   Halvorsen, Yuan Di ^a   Hillman, Robert E ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b MGH INSTITUTE OF HEALTH PROFESSIONS   (United States)

Author keywords

Avastin; Bevacizumab; Glottis; KTP laser; Larynx; Laser; Papilloma; Papillomatosis; Recurrent respiratory papillomatosis; RRP; Vocal cord; Vocal fold; Voice

Indexed keywords

BEVACIZUMAB; PHOSPHATE; POTASSIUM; TITANIUM;

ADULT; ANTIANGIOGENIC ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEALTH SURVEY; HUMAN; INJECTION; KTP LASER; LARYNX PAPILLOMATOSIS; LASER; LASER SURGERY; OPEN STUDY; PHASE 1 CLINICAL TRIAL; PHOTOANGIOLYSIS; PHOTOLYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT RESPIRATORY PAPILLOMATOSIS; REPEATED DRUG DOSE; TREATMENT OUTCOME; VOCAL CORD; VOICE; VOICE RELATED QUALITY OF LIFE SURVEY;

EID: 80053899136     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348941112001001     Document Type: Article

References (29)

1. Zeitels SM, Lopez-Guerra G, Burns JA, Lutch M, Friedman AM, Hillman RE. Microlaryngoscopic and office-based injection of bevacizumab (Avastin) to enhance 532-nm pulsed KTP laser treatment of glottal papillomatosis. Ann Otol Rhinol Laryngol Suppl 2009;118(suppl 201):1-13.
2. Hooper FH. On the treatment and recurrence of papilloma of the larynx: candidate's thesis to the American Laryngological Association. Arch Laryngol 1882;3:334-43.
3. Jako GJ, Kleinsasser O. Endolaryngeal micro-diagnosis and microsurgery. Reprint from the Annual Meeting of the American Medical Association, 1966.
4. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971;285:1182-6.
5. Folkman J. Clinical applications of research on angiogenesis. N Engl J Med 1995;333:1757-63. (Pubitemid 26009687)
6. Zeitels SM. Atlas of phonomicrosurgery and other endolaryngeal procedures for benign and malignant disease. San Diego, Calif: Singular, 2001:119-31.
7. Zeitels SM, Franco RA Jr, Dailey SH, Burns JA, Hillman RE, Anderson RR. Office-based treatment of glottal dysplasia and papillomatosis with the 585-nm pulsed dye laser and local anesthesia. Ann Otol Rhinol Laryngol 2004;113:265-76. (Pubitemid 38500470)
8. Zeitels SM, Akst LM, Burns JA, Hillman RE, Broadhurst MS, Anderson RR. Pulsed angiolytic laser treatment of ectasias and varices in singers. Ann Otol Rhinol Laryngol 2006;115:571-80. (Pubitemid 44253502)
9. Zeitels SM, Akst LM, Burns JA, Hillman RE, Broadhurst MS, Anderson RR. Office-based 532-nm pulsed KTP laser treatment of glottal papillomatosis and dysplasia. Ann Otol Rhinol Laryngol 2006;115:679-85. (Pubitemid 44449644)
10. Burns JA, Zeitels SM, Akst LM, Broadhurst MS, Hillman RE, Anderson R. 532 nm Pulsed potassium-titanyl-phosphate laser treatment of laryngeal papillomatosis under general anesthesia. Laryngoscope 2007;117:1500-4. (Pubitemid 47356862)
11. Zeitels SM, Anderson RR, Hillman RE, Burns JA. Letter to the Editor. Ann Otol Rhinol Laryngol 2007;116:317-8.
12. Zeitels SM, Burns JA. Office-based laryngeal laser surgery with the 532-nm pulsed-potassium-titanyl-phosphate laser. Curr Opin Otolaryngol Head Neck Surg 2007;15:394-400. (Pubitemid 350073465)
13. Rahbar R, Vargas SO, Folkman J, et al. Role of vascular endothelial growth factor-A in recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol 2005;114:289-95. (Pubitemid 40529984)
14. Lynch SS, Cheng CM. Bevacizumab for neovascular ocular diseases. Ann Pharmacother 2007;41:614-25. (Pubitemid 46625484)
15. Simonds J, Miller F, Mandel J, Davidson TM. The effect of bevacizumab (Avastin) treatment on epistaxis in hereditary hemorrhagic telangiectasia. Laryngoscope 2009;119:988-92.
16. Hogikyan ND, Sethuraman G. Validation of an instrument to measure voice-related quality of life (V-RQOL). J Voice 1999;13:557-69. (Pubitemid 30007814)
17. Zeitels SM, Burns JA, Lopez-Guerra G, Anderson RR, Hillman RH. Photoangiolytic laser treatment of early glottic cancer: a new management strategy. Ann Otol Rhinol Laryngol Suppl 2008;117(suppl 199):3-24.
18. Folkman J. Tumor angiogenesis. Adv Cancer Res 1985;43:175-203.
19. Folkman J. Angiogenesis. In: Braunwald E, Hauser SL, Fauci AS, Kasper DL, Longo DL, Jameson L, eds. Harrison's principles of internal medicine. 15th ed. New York, NY: McGraw-Hill, 2001:517-30.
20. Eskens FA, Sleijfer S. The use of bevacizumab in colorectal, lung, breast, renal and ovarian cancer: where does it fit? Eur J Cancer 2008;44:2350-6.
21. Incze JS, Lui PS, Strong MS, Vaughan CW, Clemente MP. The morphology of human papillomas of the upper respiratory tract. Cancer 1977;39:1634-46. (Pubitemid 8108321)
22. Zeitels SM, Vaughan CW. A submucosal true vocal fold infusion needle. Otolaryngol Head Neck Surg 1991;105:478-9.
23. Zeitels SM. Premalignant epithelium and microinvasive cancer of the vocal fold: the evolution of phonomicrosurgical management. Laryngoscope 1995;105(suppl 67):1-51.
24. Fung AE, Rosenfeld PJ, Reichel E. The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide. Br J Ophthalmol 2006;90:1344-9. (Pubitemid 44702055)
25. Wu L, Martínez-Castellanos MA, Quiroz-Mercado H, et al. Twelve-month safety of intravitreal injections of bevacizumab (Avastin): results of the Pan-American Collaborative Retina Study Group (PACORES). Graefes Arch Clin Exp Ophthalmol 2008;246:81-7. (Pubitemid 350167096)
26. Zeitels SM, Hillman RE, Bunting GW, Vaughn T. Reinke's edema: phonatory mechanisms and management strategies. Ann Otol Rhinol Laryngol 1997;106:533-43.
27. Lee AS, Rosen CA. Efficacy of cidofovir injection for the treatment of recurrent respiratory papillomatosis. J Voice 2004;18:551-6. (Pubitemid 39574528)
28. Gray SD, Titze IR, Chan R, Hammond TH. Vocal fold proteoglycans and their influence on biomechanics. Laryngoscope 1999;109:845-54. (Pubitemid 29269001)
29. N agel S, Busch C, Blankenburg T, Schütte W. Treatment of respiratory papillomatosis - a case report on systemic treatment with bevacizumab [in German]. Pneumologie 2009;63:387-9.